• Champions Oncology Inc., of Hackensack, N.J., said it signed a new discovery and drug development partnership with Teva Pharmaceutical Industries Ltd., which will use their Tumorgraft technology platform to enhance and accelerate the clinical development of several of Teva’s oncology compounds.